The short version
11 companies supply this market — deep enough that no single failure threatens the supply.
Market view
11 marketed package NDCs · 11 active manufacturers
Most dispensed: 200 mg · Capsule, Extended Release · #30 capsule, extended releases/bottle · 100 mg · Capsule, Extended Release · #30 capsule, extended releases/bottle · 150 mg · Capsule, Extended Release · #30 capsule, extended releases/bottle · 200 mg · Capsule, Extended Release · #60 capsule, extended releases/bottle
11 companies supply this market — deep enough that no single failure threatens the supply.
Every detected change for viloxazine hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in Norepinephrine Reuptake Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.